Delaware Bankruptcy Court

Case number: 1:23-bk-10606 - Phoenixus AG - Delaware Bankruptcy Court

Case Information
Case title
Phoenixus AG
Chapter
11
Judge
J Kate Stickles
Filed
05/09/2023
Last Filing
04/16/2024
Asset
Yes
Vol
v
Docket Header

PlnDue, Subchapter_V, JNTADMN, CLMSAGNT




U.S. Bankruptcy Court
District of Delaware (Delaware)
Bankruptcy Petition #: 23-10606-JKS

Assigned to: Bankruptcy Judge J Kate Stickles
Chapter 11
Voluntary
Asset


Date filed:  05/09/2023

Debtor

Phoenixus AG

600 3rd Avenue
19th Floor
New York, NY 10016
OUTSIDE U. S.
Tax ID / EIN: XX-XXXXXXX
aka
Phoenixus Ltd

aka
Turing Pharmaceuticals AG

aka
Vyera Pharmaceuticals AG


represented by
R. Craig Martin

DLA Piper LLP (US)
1201 North Martket Street
Suite 2100
Wilmington, DE 19801
302-468-5655
Fax : 302-778-7834
Email: [email protected]

Matthew Steven Sarna

DLA Piper LLP (US)
1201 N. Market Street
Suite 2100
Wilmington, DE 19801
302-468-5659
Fax : 302-397-2336
Email: [email protected]

U.S. Trustee

U.S. Trustee

Office of the United States Trustee
J. Caleb Boggs Federal Building
844 King Street, Suite 2207
Lockbox 35
Wilmington, DE 19801
(302)-573-6491

 
 
Claims Agent

Epiq Corporate Restructuring, LLC

www.epiqsystems.com
777 Third Avenue, 12th Floor
New York, NY 10017
646-282-2500
 
 

Latest Dockets
Date Filed#Docket Text
06/05/20236Docket Text
Schedules/Statements filed: , Stmt of Financial Affairs,. Filed by Phoenixus AG. (Sarna, Matthew) (Entered: 06/05/2023)
06/05/20235Docket Text
Schedules/Statements filed: Sch A-B, Sch D, Sch E-F, Sch G, Sch H, , Sum of Assets and Liabilities, Decl Concerning Debtors Schs,. Filed by Phoenixus AG. (Sarna, Matthew) (Entered: 06/05/2023)
05/18/20234Docket Text
Order Authorizing (1) The Joint Administration Of The Debtor's Subchapter V Cases And (II) Granting Related Relief "An Order has been entered in this case directing the proceduralconsolidation and joint administration of the subchapter V cases of Vyera Pharmaceuticals, LLC (1758); Oakrum Pharma, LLC (3999); SevenScore Pharmaceuticals, LLC (2598); Phoenixus AG (1091); Dermelix Biotherapeutics, LLC (4711); and Orpha Labs AG. The Debtors headquarters and the mailing address for the Debtors is 600 3rd Avenue, 19th Floor, New York, NY 10016. The docket in the subchapter V case of Vyera Pharmaceuticals, LLC, Case No. 23-10605, should be consulted for all matters affecting this case. Alternatively, information concerning these jointly administered subchapter V cases may be obtained by visiting the website of the Debtors claims and noticing agent: http://dm.epiq11.com/Vyera." Signed on 5/18/2023 (AJL) (Entered: 05/18/2023)
05/18/20233Docket Text
Motion for Joint Administration Filed by Dermelix Biotherapeutics, LLC, Oakrum Pharma, LLC, Orpha Labs AG, Phoenixus AG, SevenScore Pharmaceuticals, LLC. (Sarna, Matthew) (Entered: 05/18/2023)
05/10/2023Docket Text
Judge J Kate Stickles added to case (SJS) (Entered: 05/10/2023)
05/09/20232Docket Text
Receipt of filing fee for Voluntary Petition (Chapter 11)( 23-10606) [misc,volp11a] (1738.00). Receipt Number A11086414, amount $1738.00. (U.S. Treasury) (Entered: 05/09/2023)
05/09/20231Docket Text
Chapter 11 Voluntary Petition . Fee Amount $1738. Filed by Phoenixus AG. Chapter 11 Plan Small Business Subchapter V Due by 08/7/2023. (Martin, R.) Modified text on 5/10/2023 (MMD). (Entered: 05/09/2023)